Showing results (1501-1510 of 5,535) with videos related to

Sort By:
Pageof 554
Inflammatory Bowel Diseases|October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Inflammatory Bowel Diseases|October 12, 2011
Clinical epidemiology of Crohn's disease in Arabs based on the Montreal ClassificationIqbal Siddique, Waleed Alazmi, Jaber Al-Ali, et al.
Inflammatory Bowel Diseases|November 15, 2011
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trialKoji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, et al.
Inflammatory Bowel Diseases|November 15, 2011
Matriptase protects against experimental colitis and promotes intestinal barrier recoverySarah Netzel-Arnett, Marguerite S Buzza, Terez Shea-Donohue, et al.
Inflammatory Bowel Diseases|November 15, 2011
One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitisA Barney Hawthorne, Rachel Stenson, David Gillespie, et al.
Inflammatory Bowel Diseases|December 14, 2011
Ulcerative colitis as a progressive disease: the forgotten evidenceJoana Torres, Vincent Billioud, David B Sachar, et al.
Inflammatory Bowel Diseases|May 2, 2009
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patientsPál Miheller, Györgyi Muzes, István Hritz, et al.
Inflammatory Bowel Diseases|May 2, 2009
Resource use and societal costs for Crohn's disease in SwedenJohan Mesterton, Linus Jönsson, Sven H C Almer, et al.
Inflammatory Bowel Diseases|May 2, 2009
Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvementJavier P Gisbert, Fernando Bermejo, Ramón Pajares, et al.
Inflammatory Bowel Diseases|May 2, 2009
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximabWaqqas Afif, Jonathan A Leighton, Stephen B Hanauer, et al.
Pageof 554